Funding to support development of antibiotics, vaccines, diagnostics and other life-saving drugs against drug resistant bacteria

CARB-X, a global partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria, announced their 2019 rounds for funding various research projects.

There are four funding rounds. Each of the four rounds has a specific scope and application period.

Please see this link for more information: